vs
Dollar Tree（DLTR）与通用电气医疗（GEHC）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是Dollar Tree的1.2倍（$5.7B vs $4.7B），通用电气医疗净利率更高（10.3% vs 5.2%，领先5.2%），通用电气医疗同比增速更快（7.1% vs -37.2%），过去两年通用电气医疗的营收复合增速更高（10.7% vs -25.9%）
Dollar Tree是美国多价位折扣百货连锁企业，位列《财富》500强，总部位于弗吉尼亚州切萨皮克。公司在美国本土48个毗连州及加拿大共运营15115家门店，旗下24个配送中心组成的全国物流网络为所有门店提供运营支持。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、核磁共振、女性健康筛查、X射线系统）、超声、患者护理解决方案（聚焦远程患者监测、麻醉呼吸护理、心脏病诊断、婴幼儿照护）及制药诊断业务。
DLTR vs GEHC — 直观对比
营收规模更大
GEHC
是对方的1.2倍
$4.7B
营收增速更快
GEHC
高出44.3%
-37.2%
净利率更高
GEHC
高出5.2%
5.2%
两年增速更快
GEHC
近两年复合增速
-25.9%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.7B | $5.7B |
| 净利润 | $244.6M | $588.0M |
| 毛利率 | 35.8% | 39.7% |
| 营业利润率 | 7.2% | 14.5% |
| 净利率 | 5.2% | 10.3% |
| 营收同比 | -37.2% | 7.1% |
| 净利润同比 | 4.8% | -18.4% |
| 每股收益（稀释后） | $1.20 | $1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DLTRGEHC
| Q4 25 | $4.7B | $5.7B | ||
| Q3 25 | $4.6B | $5.1B | ||
| Q2 25 | $4.6B | $5.0B | ||
| Q1 25 | $5.0B | $4.8B | ||
| Q4 24 | $7.6B | $5.3B | ||
| Q3 24 | $7.4B | $4.9B | ||
| Q2 24 | $7.6B | $4.8B | ||
| Q1 24 | $8.6B | $4.7B |
净利润DLTRGEHC
| Q4 25 | $244.6M | $588.0M | ||
| Q3 25 | $188.4M | $446.0M | ||
| Q2 25 | $343.4M | $486.0M | ||
| Q1 25 | $-3.7B | $564.0M | ||
| Q4 24 | $233.3M | $721.0M | ||
| Q3 24 | $132.4M | $470.0M | ||
| Q2 24 | $300.1M | $428.0M | ||
| Q1 24 | $-1.7B | $374.0M |
毛利率DLTRGEHC
| Q4 25 | 35.8% | 39.7% | ||
| Q3 25 | 34.4% | 38.7% | ||
| Q2 25 | 35.6% | 39.6% | ||
| Q1 25 | 37.6% | 42.1% | ||
| Q4 24 | 30.9% | 42.8% | ||
| Q3 24 | 30.0% | 41.7% | ||
| Q2 24 | 30.8% | 41.4% | ||
| Q1 24 | 32.1% | 40.9% |
营业利润率DLTRGEHC
| Q4 25 | 7.2% | 14.5% | ||
| Q3 25 | 5.1% | 12.7% | ||
| Q2 25 | 8.3% | 13.1% | ||
| Q1 25 | — | 13.2% | ||
| Q4 24 | 4.4% | 15.1% | ||
| Q3 24 | 2.8% | 13.9% | ||
| Q2 24 | 5.5% | 12.6% | ||
| Q1 24 | -21.9% | 11.6% |
净利率DLTRGEHC
| Q4 25 | 5.2% | 10.3% | ||
| Q3 25 | 4.1% | 8.7% | ||
| Q2 25 | 7.4% | 9.7% | ||
| Q1 25 | -74.0% | 11.8% | ||
| Q4 24 | 3.1% | 13.6% | ||
| Q3 24 | 1.8% | 9.7% | ||
| Q2 24 | 3.9% | 8.8% | ||
| Q1 24 | -19.8% | 8.0% |
每股收益（稀释后）DLTRGEHC
| Q4 25 | $1.20 | $1.28 | ||
| Q3 25 | $0.91 | $0.98 | ||
| Q2 25 | $1.61 | $1.06 | ||
| Q1 25 | $-17.17 | $1.23 | ||
| Q4 24 | $1.08 | $1.58 | ||
| Q3 24 | $0.62 | $1.02 | ||
| Q2 24 | $1.38 | $0.93 | ||
| Q1 24 | $-7.78 | $0.81 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $594.8M | $4.5B |
| 总债务越低越好 | — | $10.0B |
| 股东权益账面价值 | $3.5B | $10.4B |
| 总资产 | $13.7B | $36.9B |
| 负债/权益比越低杠杆越低 | — | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资DLTRGEHC
| Q4 25 | $594.8M | $4.5B | ||
| Q3 25 | $666.3M | $4.0B | ||
| Q2 25 | $1.0B | $3.7B | ||
| Q1 25 | $1.3B | $2.5B | ||
| Q4 24 | $697.6M | $2.9B | ||
| Q3 24 | $570.3M | $3.5B | ||
| Q2 24 | $618.5M | $2.0B | ||
| Q1 24 | $684.9M | $2.6B |
总债务DLTRGEHC
| Q4 25 | — | $10.0B | ||
| Q3 25 | — | $10.3B | ||
| Q2 25 | — | $10.3B | ||
| Q1 25 | $3.4B | $8.8B | ||
| Q4 24 | — | $9.0B | ||
| Q3 24 | — | $10.3B | ||
| Q2 24 | — | $9.2B | ||
| Q1 24 | $3.4B | $9.3B |
股东权益DLTRGEHC
| Q4 25 | $3.5B | $10.4B | ||
| Q3 25 | $3.6B | $10.0B | ||
| Q2 25 | $3.9B | $9.7B | ||
| Q1 25 | $4.0B | $9.2B | ||
| Q4 24 | $7.6B | $8.4B | ||
| Q3 24 | $7.4B | $8.3B | ||
| Q2 24 | $7.3B | $7.8B | ||
| Q1 24 | $7.3B | $7.4B |
总资产DLTRGEHC
| Q4 25 | $13.7B | $36.9B | ||
| Q3 25 | $13.4B | $36.1B | ||
| Q2 25 | $18.3B | $35.5B | ||
| Q1 25 | $18.6B | $33.6B | ||
| Q4 24 | $23.3B | $33.1B | ||
| Q3 24 | $22.6B | $33.9B | ||
| Q2 24 | $22.1B | $31.9B | ||
| Q1 24 | $22.0B | $32.2B |
负债/权益比DLTRGEHC
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | 0.86× | 0.95× | ||
| Q4 24 | — | 1.06× | ||
| Q3 24 | — | 1.24× | ||
| Q2 24 | — | 1.18× | ||
| Q1 24 | 0.47× | 1.25× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $319.3M | — |
| 自由现金流经营现金流 - 资本支出 | $-57.1M | — |
| 自由现金流率自由现金流/营收 | -1.2% | — |
| 资本支出强度资本支出/营收 | 7.9% | 2.4% |
| 现金转化率经营现金流/净利润 | 1.31× | — |
| 过去12个月自由现金流最近4个季度 | $394.5M | — |
8季度趋势，按日历期对齐
经营现金流DLTRGEHC
| Q4 25 | $319.3M | — | ||
| Q3 25 | $260.7M | — | ||
| Q2 25 | $378.5M | $94.0M | ||
| Q1 25 | $405.1M | $250.0M | ||
| Q4 24 | $785.6M | — | ||
| Q3 24 | $306.9M | — | ||
| Q2 24 | $695.7M | $-119.0M | ||
| Q1 24 | $1.3B | $419.0M |
自由现金流DLTRGEHC
| Q4 25 | $-57.1M | — | ||
| Q3 25 | $15.6M | — | ||
| Q2 25 | $129.7M | $8.0M | ||
| Q1 25 | $306.3M | $98.0M | ||
| Q4 24 | $359.2M | — | ||
| Q3 24 | $-193.8M | — | ||
| Q2 24 | $223.5M | $-183.0M | ||
| Q1 24 | $470.8M | $274.0M |
自由现金流率DLTRGEHC
| Q4 25 | -1.2% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 2.8% | 0.2% | ||
| Q1 25 | 6.1% | 2.1% | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | -2.6% | — | ||
| Q2 24 | 2.9% | -3.8% | ||
| Q1 24 | 5.5% | 5.9% |
资本支出强度DLTRGEHC
| Q4 25 | 7.9% | 2.4% | ||
| Q3 25 | 5.4% | 2.1% | ||
| Q2 25 | 5.4% | 1.7% | ||
| Q1 25 | 2.0% | 3.2% | ||
| Q4 24 | 5.6% | 1.9% | ||
| Q3 24 | 6.8% | 1.9% | ||
| Q2 24 | 6.2% | 1.3% | ||
| Q1 24 | 9.1% | 3.1% |
现金转化率DLTRGEHC
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.38× | — | ||
| Q2 25 | 1.10× | 0.19× | ||
| Q1 25 | — | 0.44× | ||
| Q4 24 | 3.37× | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.32× | -0.28× | ||
| Q1 24 | — | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DLTR
| Consumable | $2.4B | 50% |
| Variety | $2.1B | 43% |
| Seasonal | $344.1M | 7% |
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
